Home » Topics » Regulatory » EMA

EMA
RSS

Amgen and Onyx file applications to expand approval of carfilzomib in the E.U. and U.S.

Jan. 28, 2015

EMA adopts positive opinion on Ikervis eye drops

Jan. 27, 2015

EMA grants orphan drug designation to ApoCell for GVHD

Jan. 27, 2015

EMA CHMP recommends approval of lamivudine/raltegravir for HIV-1 infection

Jan. 27, 2015

Cubist's tedizolid phosphate recommended for approval in E.U. for ABSSSI

Jan. 26, 2015

The Medicines Company receives CHMP recommendations for three acute care products

Jan. 26, 2015

European CHMP recommends new approval of Eylea

Jan. 26, 2015

EMA recommends approval of Abraxane for NSCLC

Jan. 26, 2015

EMA committee recommends approval of Saxenda for weight management

Jan. 26, 2015

Jakavi recommended for approval in Europe for polycythemia vera

Jan. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...